NEUROONE MEDICAL TECHNOLOGIE (NMTC)
US64130M2098 - Common Stock
ChartMill assigns a Buy % Consensus number of 43% to NMTC. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 3.21. This target is 184.34% above the current price.
NMTC was analyzed by 6 analysts. The buy percentage consensus is at 43. So analysts seem to be rather negative about NMTC.
In the last month the buy percentage fell by 37 points. So the trust of analysts is decreasing.
NMTC was analyzed by 6 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2023-08-15 | Alliance Global Partners | Maintains | Buy -> Buy |
| 2021-12-03 | Alliance Global Partners | Initiate | Buy |
| 2021-11-15 | Craig-Hallum | Initiate | Buy |